Latest News

Audentes Therapeutics Announces Plans to Build New State-of-the-Art Gene Therapy Manufacturing Facility in Sanford, North Carolina

SAN FRANCISCO & RALEIGH, N.C.–(BUSINESS WIRE)–Audentes Therapeutics, an Astellas company focused on developing innovative AAV-based genetic medicines, announced today that it plans to invest $109 million to build a new 135,000 square foot, state-of-the-art gene therapy manufacturing facility in Sanford, North Carolina. The initial phase of the capital investment is planned to occur over approximately 18 months, and the plant is expected to be operational in 2021. The remaining investment will

Source link

Related posts

Fighting With Your Spouse Could Increase Bacteria Levels In Blood


Working Overtime Could Raise Women’s Diabetes Risk


Good News for Parents: Many Preemie Babies Grow Up Fine


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World